The enhancement of the oral bioavailability of γ-tocotrienol in mice by γ-cyclodextrin inclusion

Journal of Nutritional Biochemistry

Volumn 22, Issue 12, 2011, Pages 1121-1126

  Miyoshi, Noriyuki ^a   Wakao, Yohei ^a   Tomono, Susumu ^a   Tatemichi, Masayuki ^a,b   Yano, Tomohiro ^a,c   Ohshima, Hiroshi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Cyclodextrin; Tocotrienol; Inclusion complex; Oral bioavailability

Indexed keywords

ALPHA TOCOPHEROL; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; GAMMA CYCLODEXTRIN; GAMMA TOCOTRIENOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; C57BL 6 MOUSE; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUTRITION; PHYSIOLOGY; RICE BRAN;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHROMANS; GAMMA-CYCLODEXTRINS; LIPOPOLYSACCHARIDES; MALE; MICE; VITAMIN E;

ESCHERICHIA COLI; MUS;

EID: 80054947242     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.09.011     Document Type: Article

References (38)

1. Sen C.K., Khanna S., Roy S. Tocotrienols: vitamin E beyond tocopherols. Life Sci 2006, 78:2088-2098.
2. Sen C.K., Khanna S., Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med 2007, 28:692-728.
3. Zingg J.M. Vitamin E: an overview of major research directions. Mol Aspects Med 2007, 28:400-422.
4. Panfili G., Fratianni A., Irano M. Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. J Agric Food Chem 2003, 51:3940-3944.
5. Sugano M., Koba K., Tsuji E. Health benefits of rice bran oil. Anticancer Res 1999, 19:3651-3657.
6. Qureshi A.A., Pearce B.C., Nor R.M., Gapor A., Peterson D.M., Elson C.E. Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J Nutr 1996, 126:389-394.
7. Qureshi A.A., Bradlow B.A., Brace L., Manganello J., Peterson D.M., Pearce B.C., et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 1995, 30:1171-1177.
8. Qureshi A.A., Qureshi N., Hasler-Rapacz J.O., Weber F.E., Chaudhary V., Crenshaw T.D., et al. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 1991, 53:1042S-1046S.
9. Qureshi A.A., Qureshi N., Wright J.J., Shen Z., Kramer G., Gapor A., et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (PalmVitee). Am J Clin Nutr 1991, 53:S1021-S1026.
10. Qureshi A.A., Burger W.C., Peterson D.M., Elson C.E. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 1986, 261:10544-10550.
11. Theriault A., Chao J.T., Wang Q., Gapor A., Adeli K. Tocotrienol: a review of its therapeutic potential. Clin Biochem 1999, 32:309-319.
12. Nesaretnam K., Stephen R., Dils R., Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 1998, 33:461-469.
13. Miyazawa T., Shibata A., Sookwong P., Kawakami Y., Eitsuka T., Asai A. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol). J Nutr Biochem 2009, 20:79-86.
14. Szejtli J. Medicinal applications of cyclodextrins. Med Res Rev 1994, 14:353-386.
15. Stella V.J., Rajewski R.A. Cyclodextrins: their future in drug formulation and delivery. Pharm Res 1997, 14:556-567.
16. Uekama K., Hirayama F., Irie T. Cyclodextrin drug carrier systems. Chem Rev 1998, 98:2045-2076.
17. Thompson D.O. Cyclodextrins - enabling excipients: their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 1997, 14:1-104.
18. 10 in beagle dogs. J Pharm Biomed Anal 2008, 47:918-922.
19. Yadav V.R., Suresh S., Devi K., Yadav S. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech 2009, 10:752-762.
20. American Institute of Nutrition Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 1997, 107:1340-1348.
21. Yap S.P., Julianto T., Wong J.W., Yuen K.H. Simple high-performance liquid chromatographic method for the determination of tocotrienols in human plasma. J Chromatogr B Biomed Sci Appl 1999, 735:279-283.
22. Gibaldi M., Perrier D. Pharmacokinetics. 2nd ed. Drugs and the pharmaceutical sciences 1982, Marcel Dekker, New York.
23. Chiou W.L. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. Journal of Pharmacokinet Biopharm 1978, 6:539-546.
24. Ikeda S., Uchida T., Ichikawa T., Watanabe T., Uekaji Y., Nakata D., et al. Complexation of tocotrienol with gamma-cyclodextrin enhances intestinal absorption of tocotrienol in rats. Biosci Biotechnol Biochem 2010, 74:1452-1457.
25. Marshall J.J., Miwa I. Kinetic difference between hydrolyses of gamma-cyclodextrin by human salivary and pancreatic alpha-amylases. Biochim Biophys Acta 1981, 661:142-147.
26. Kondo H., Nakatani H., Hiromi K. In vitro action of human and porcine alpha-amylases on cyclomalto-oligosaccharides. Carbohydr Res 1990, 204:207-213.
27. 14C]gamma-cyclodextrin in germ-free and conventional rats. Regul Toxicol Pharmacol 1998, 27:150-158.
28. Lai CS, Chow JM, Wolf BW. (2005) Methods of using gamma cyclodextrin to control blood glucose and insulin secretion. US Patent 20050215523 A1.
29. Waalkens-Berendsen D.H., Smits van Prooije A.E., Bar A. Embryotoxicity and teratogenicity study with gamma-cyclodextrin in rabbits. Regul Toxicol Pharmacol 1998, 27:172-177.
30. Waalkens-Berendsen D.H., Verhagen F.J., Bar A. Embryotoxicity and teratogenicity study with gamma-cyclodextrin in rats. Regul Toxicol Pharmacol 1998, 27:166-171.
31. Munro I.C., Newberne P.M., Young V.R., Bar A. Safety assessment of gamma-cyclodextrin. Regul Toxicol Pharmacol 39 Suppl 2004, 1:S3-S13.
32. Li Z., Wang M., Wang F., Gu Z., Du G., Wu J., et al. gamma-Cyclodextrin: a review on enzymatic production and applications. Appl Microbiol Biotechnol 2007, 77:245-255.
33. 10 by complexation with γ-cyclodextrin in healthy adults. Nutr Res 2006, 26:503-508.
34. Suzuki Y.J., Tsuchiya M., Wassall S.R., Choo Y.M., Govil G., Kagan V.E., et al. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 1993, 32:10692-10699.
35. Packer L., Weber S.U., Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr 2001, 131:S369-S373.
36. Reiter E., Jiang Q., Christen S. Anti-inflammatory properties of alpha- and gamma-tocopherol. Mol Aspects Med 2007, 28:668-691.
37. Singh U., Devaraj S., Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005, 25:151-174.
38. Meydani M., Koga T., Ali S. Vitamin E deficiency. Encyclopedia of life sciences 2003, John Wiley & Sons, Chichester, Available from, [doi:10.1038/npg.els.0006101]. http://www.els.net/.